Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Sepetaprost - Santen Pharmaceutical

Next Previous
Drug Profile

Sepetaprost - Santen Pharmaceutical

Alternative Names: DE 126; ONO 9054; STN-10126; STN-1012600

Latest Information Update: 17 Dec 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ono Pharmaceutical
  • Developer Ono Pharmaceutical; Santen Pharmaceutical
  • Class Antiglaucomas; Oxepins; Prostaglandins
  • Mechanism of Action Prostaglandin E EP3 receptor agonists; Prostaglandin F2 alpha agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preregistration Ocular hypertension; Open-angle glaucoma

Most Recent Events

  • 26 Sep 2024 Preregistration for Ocular hypertension in Japan (Ophthalmic),
  • 26 Sep 2024 Preregistration for Open-angle glaucoma in Japan (Ophthalmic),
  • 26 Sep 2024 Adverse events and efficacy data from a phase-III trial in Ocular hypertension and Open-angle glaucoma released by Santen Pharmaceutical ,

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top